Concepedia

Andrew Kroeker

AK

Statistics

Publications

14

Citations

1.1K

H-Index

13

Active since

2001

Affiliations

Sarepta Therapeutics (United States)(Current)

Oregon State University

Oregon Health & Science University

Scripps Research Institute

London Health Sciences Centre

Andrew Kroeker is an author at Sarepta Therapeutics (United States) specializing in infectious diseases, viral infections, and virology.

Publications per year

2001–2010

14

Publications

14

VP35 Knockdown Inhibits Ebola Virus Amplification and Protects against Lethal Infection in Mice

Sven Enterlein, Kelly L. Warfield, Dana L. Swenson et al. · Antimicrobial Agents and Chemotherapy · 2006 · 120 citations

, , +15

Inhibition of Dengue Virus Serotypes 1 to 4 in Vero Cell Cultures with Morpholino Oligomers

Richard M. Kinney, Claire Y.‐H. Huang, Becky C. Rose et al. · Journal of Virology · 2005 · 117 citations · Full text

, , +12

Inhibition, Escape, and Attenuated Growth of Severe Acute Respiratory Syndrome Coronavirus Treated with Antisense Morpholino Oligomers

Benjamin W. Neuman, David A. Stein, Andrew Kroeker et al. · Journal of Virology · 2005 · 112 citations

, , +17

Long-term morbidity, pain, and disability after repair of severe chest wall injuries.

John C. Mayberry, Andrew Kroeker, L Bruce Ham et al. · PubMed · 2009 · 111 citations

, , +13

An operating cost comparison between conventional and home quotidian hemodialysis

Andrew Kroeker, William F. Clark, A.Paul Heidenheim et al. · American Journal of Kidney Diseases · 2003 · 109 citations

, , +14

1–5 of 14